Memilih bentuk atap rumah yang tepat merupakan keputusan penting, baik saat pembangunan maupun renovasi rumah. Karena setiap model atap memiliki karakteristik, kelebihan, dan kekurangan yang berbeda, ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

Bangladesh has signed a memorandum of understanding (MoU) with Pakistan to import atap (parboiled) rice on a government-to-government (G2G) basis. Trading Corporation of Pakistan Chairman Syed Rafeo ...

Bangladesh has signed a Memorandum of Understanding (MoU) with Pakistan to import atap (parboiled) rice. The MoU was signed by Sayed Rafeo Bashir Shah, Chairman of the Trading Corporation of ...

A memorandum of understanding (MoU) has been signed to import Atap rice on a government-to-government (G2G) basis from Pakistan. The Trading Corporation of Pakistan (TCP) and Bangladesh’s Directorate ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda for patient convenience as the company approaches a steep patent ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...